Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursobil for reduction of bilirubin in neonatal jaundice
IRCT201701313915N18Phase 2Completed
- Sponsor
- Research vice chancellor of Tabriz University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ursodeoxycholic acid in jaundice, sponsored by Research vice chancellor of Tabriz University of Medical Sciences. Primary endpoint: Change in total serum bilirubin. Started Jan 2017; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT201701313915N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201701313915N18.